Skip to content

Medical-device intelligence

NQF: Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor

FDA product code NQF: Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NQF
FDA device name
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
Device class
3
Regulation number
864.1860
Medical specialty
Hematology
Review panel
PA

FDA definition

The epidermal growth factor receptor (EGFR) antibody/assay is a qualitative immunohistochemical antibody/assay to identify EGFR expression in normal and neoplastic tissues routinely-fixed for histological evaluation. EGFR antibody/assay specifically detects the EGFR (HER1) protein in EGFR-expressing cells. This antibody/assay is indicated as an aid in identifying colorectal cancer patients eligible for treatment with cetuximab, a monoclonal antibody drug. This will be a specialized subcategory for EGFR immunohistochemistry assays under the general heading of the regulation for all Immunohistochemistry assays.
Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

0 clearance records and 0 recall records in the covered releases, across 0 source company names and 0 product codes. No dated record history is available in this scope.

No records in these releases does not establish that a device has never been marketed, cleared, or recalled. Classification entries can exist without a matching clearance or recall in the covered datasets. Consult the original classification and the appropriate FDA pathway.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

0 matching records
No matching records in the current covered data. This does not establish that a product is unmarketed or free of recalls. Check the source coverage and try broader criteria.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗